Palmitoylethanolamide (PEA) yog dab tsi?
Palmitoylethanolamide (PEA) yog ib qho tshwm sim hauv lub cev uas pab tiv thaiv qhov mob thiab mob. Nws kuj yog tsim los ntawm ntau yam tsiaj thiab nroj tsuag, nrog rau qhov siab tshaj plaws concentrations pom nyob rau hauv soy lecithin, soy, qe qe, txiv laum huab xeeb, thiab alfalfa. PEA yog technically hu ua "pro-resolving lipid mediator." Qhov no txhais tau hais tias PEA cuam tshuam rau kev tswj hwm hauv nruab nrab hauv cov hlwb, daws qhov mob thiab kev ntxhov siab ntawm tes. Ntau tshaj 600 qhov kev tshawb fawb tshawb fawb tau pom tias nws muaj txiaj ntsig zoo heev.
PEA muaj ntau yam kev siv tshuaj kho mob, tab sis nws cov kev tshawb fawb thiab kev siv nrov yog tsom rau nws cov tshuaj tiv thaiv kab mob thiab tshuaj tua kab mob hauv cov kab mob xws li mob nraub qaum, sciatica, thiab osteoarthritis. Preclinical thiab tib neeg cov kev tshawb fawb kuj tau tshawb xyuas nws cov teebmeem ntawm kev nyuaj siab, txhim kho kev txawj ntse thiab kev nco, autism spectrum disorders, ntau yam sclerosis, rog, thiab metabolic syndrome. PEA muaj ntau yam zoo ib yam li cannabidiol (CBD), tab sis nws siv tau zoo dua los ntawm kev tshawb fawb, uas yog nws qhov zoo dua.
Nkag siab txog cov txheej txheem ntawm kev ua ntawm Palmitoylethanolamide
Cov txiaj ntsig kev noj qab haus huv ntawm palmitoylethanolamide bulk hmoov muaj xws li cuam tshuam lub cev tiv thaiv kab mob uas tswj kev mob (tshwj xeeb hauv lub hlwb). PEA tuaj yeem pab txo qis kev tsim cov tshuaj inflammatory. Txawm li cas los xij, PEA feem ntau ua rau ntawm cov cellular receptors uas tswj ntau yam ntawm cov cellular muaj nuj nqi. Cov receptors no hu ua PPAR. Taum pauv thiab lwm cov chaw sib txuas uas pab qhib cov roj av, ua kom muaj cov roj ntsha zom, txhim kho cov ntshav qab zib, thiab pab kom poob phaus.
Yog tias Palmitoylethanolamide tuaj yeem pab txo qis kev mob hlwb, nws puas tuaj yeem ua haujlwm rau lwm yam teeb meem hauv hlwb?
Yog lawm, PEA muaj cov txheej txheem dav dav uas ua lub luag haujlwm tseem ceeb hauv kev mob ntev, kev paub txog kev ua haujlwm, thiab kev nyuaj siab. Muaj ntau cov pov thawj uas PEA ua lub luag haujlwm tseem ceeb hauv kev txo qis kev nyuaj siab vim yog kev puas hlwb thiab mob ntev. Tsiaj cov qauv ntawm kev nyuaj siab thiab tib neeg ob qhov muag tsis pom kev siv cov placebo-tswj kev sim muaj tag nrho cov tshuaj tiv thaiv kev nyuaj siab. Cov kev tshawb fawb kuj tau pom tias PEA tuaj yeem pab daws cov lus teb rau kev ntxhov siab, yog li muab kev tiv thaiv tseem ceeb tiv thaiv kev ntxhov siab thiab kev ntxhov siab.
Palmitoylethanolamide (PEA) muaj kev kho mob zoo txog kab mob:
● Mob nraub qaum
● Sciatica
● Osteoarthritis
● Fibromyalgia
● Carpal tunnel syndrome
● Peripheral neuropathy -diabetic neuropathy & chemotherapy-induced peripheral neuropathy
● Neuropathic mob -stroke-txog & ntau yam sclerosis
● Mob hniav
● Mob pelvic thiab qhov chaw mos
● Postherpetic neuralgia los ntawm cov kab mob ntawm daim tawv nqaij
Palmitoylethanolamide (PEA) muaj kev nyab xeeb kiag li thiab tsis muaj tshuaj lom, thiab hauv tib neeg kev sim tshuaj, PEA tsis muaj qhov cuam tshuam loj rau kev kho mob. Tsis paub tias muaj kev cuam tshuam tshuaj nrog PEA.